董事会

董事TDG板从一系列行业,包括生物医药,工程,金融,私募股权和风险资本由澳彩网杰出的教师和管理人员。董事会成员在作出战略投资决策,监督和指导,以TDG的活动提供指导。

William Mitchell headshot

威廉·米切尔,董事长

创始合伙人,续集合资伙伴,LLC

威廉即(法案)米切尔是续集合资伙伴,有限责任公司,成立于2010年1月投资于管理IT服务利用风险投资,私募股权投资和其他投资工具公司的创始合伙人。在此之前,先生。米切尔董事长兼首席执行官艾睿电子的,INC。,$ 20十亿的财富150公司的技术行业提供先进的供应链解决方案。他在2003年2月担任总裁兼首席执行官加入箭头。他被任命为2006年5月先生董事长。米切尔退休的董事长兼首席执行官于2010年1月1日。

先生。米切尔开始了他的职业生涯1973年在Raychem公司,在那里,他在财政责任的增加,制造业务,国际业务,以及全球销售和营销的各种角色花了20年。在1993年,他被任命为纳舒厄公司的总裁兼首席执行官,特色产品和服务,为打印应用需求的制造商。在1995年,他成为董事长,总裁兼续集,INC。,则私人持有计算机服务和维修公司的首席执行官。在接合之前的箭头,先生。米切尔出售续集INC。到Solectron公司,然后带领成功组建旭电全球服务,$ 1.2十亿技术服务的公司,目前伟创力国际的一部分。

目前,先生。米切尔担任Rogers公司的董事,他在那里担任首席独立董事的董事会; Humana公司注册成立,在那里他担任审计和提名/治理委员会;公司和Spansion公司合并,他在那里担任提名/治理委员会主席以及薪酬委员会。他之前出售给德州仪器担任国家半导体的董事会,还有百富门公司,在那里他是审计委员会主席。他是澳彩网的基础主席当选人,并任职于澳彩网的基础上,澳彩网的投资公司,而董事会在阿瑟顿,加利福尼亚州,他担任执行委员会在门洛帕克学校的董事会成员。

Tom Unterman headshot

汤姆unterman,名誉主席

创始合伙人,质朴的峡谷伙伴

Tom is the founding partner of Rustic Canyon Partners, one of the largest venture capital firms in Los Angeles. Through Rustic Canyon, he has raised venture funds in excess of $800 million. Among his notable investments are Netscape, LoopNet, Glass Lewis, and Fulcrum Bioenergy. Prior to forming Rustic Canyon Partners, Mr. Unterman had a long career as a corporate executive. From 1992 to 1999, he held several executive positions at Times Mirror Company, including Executive Vice President and Chief Financial Officer. At Times Mirror, he led the acquisition and divestiture activity and oversaw the investment program. Prior to joining Times Mirror, Tom was one of California’s leading corporate attorneys, practicing first with 要么rick, Herrington from 1969 to 1986 and then with Morrison & Foerster from 1986 to 1992.

汤姆还担任mediaspan集团的董事长,INC。,和agribuys的董事,bassoe近海,在线foodlink,LLC,交易有限责任公司,SLS微风控股有限公司,实践技术,riverone INC。他一直支点生物能源的董事INC。自2007年8月,元k公司自2000年2月和worldres.com,INC。自1999年3月,他担任新软NSI SA的董事,跨音速燃烧,INC。,消耗臭氧层物质的石油数据,INC。(替代名称IHS石油数据,INC。),技术好,INC。,强悍的学习解决方案,INC。 ,导航癌症,INC。,realpractice,INC。和icopyright,INC。他作为在美国的顾问委员会的成员可再生能源集团有限责任公司。他一直在黑线系统一直顾问委员会的成员公司,。自2011年3月10日。

汤姆主动担任加州社区基金会的董事会成员,加州艺术学院,愈合海湾,和MoCA。

诺曼艾布拉姆斯 headshot

诺曼艾布拉姆斯

法退休,澳彩网的特聘教授

诺曼担任2006 - 2007年在澳彩网代理校长。他从法学院教授退休于2007年,代理校长名誉和法律名誉特聘教授的头衔,但他已经被召回,并继续教和反恐怖主义法,联邦刑法和证据方面写。

艾布拉姆斯加盟澳彩网法学院的教师和自1959年以来一直是澳彩网家族的成员1991年至2001年他担任学术人员的澳彩网的副校长,负责教师任命和晋升校园。他2012年5月担任从2003年法学院的临时院长至2004年,和早期曾担任副院长,从1989年到1991年,艾布拉姆斯收到澳彩网荣休讲座教授协会,这是他们一生授予最高荣誉奖杰出服务奖。

艾布拉姆斯联邦刑法,联邦刑法及其执法突破性记录簿第五版(与比尔和克莱因),发表于2010年的他的书另一个,反恐和刑事执法,(第4版,2012),是第一个案例书与反恐怖主义法的迅速发展的领域和刑事执法过程中全面处理。他也是证据的合着者 - (。与法官杰克·B·温斯坦等)的情况和材料。在他漫长的职业生涯,他写了许多科目,包括起诉自由裁量权,联邦管辖,阴谋法,证据特权,最近,反恐。

澳彩网加盟之前,艾布拉姆斯担任哥伦比亚大学法学院法律联营和哈佛 - 布兰代斯合作研究对以色列在哈佛法学院法律发展的研究助理和导演。他也一直是顾问,不同的州和联邦委员会和专业委员会,并同时在澳彩网休假,在1966-67赛季,他被任命为特别助理,美国总检察长,在刑事庭服务美国司法部。他曾任教于斯坦福大学法学院访问教授,加州大学伯克利分校法学院,法律的希伯来大学教授,法律的巴伊兰大学学院,南加州大学法学院和洛约拉大学(洛杉矶)法学院。

法布里奇奥bonanni headshot

法布里奇奥bonanni

执行副总裁安进(退)

博士。法布里奇奥bonanni从他作为安进公司,是世界上最大的独立生物技术公司执行副总裁位置上退休2013。在他14年安进公司,他担任高级副总裁,质量,合规性和公司合规官,高级副总裁,制造,最后执行副总裁运营,监督公司的全球生产和供应链活动以及质量,工艺开发,药物输送设备,工程,环境,健康和安全。

而在安进,bonanni曾担任加州科学中心的理事,当代艺术的洛杉矶博物馆,波多黎各的科学技术和研究的信任,并作为加州医疗保健研究所的董事会成员。他还担任生物,生物技术行业协会董事会执行委员会共同主持了知识产权委员会。

此前,他是公司副总裁,监管和临床事务和公司副总裁,百特国际公司的质量体系,一个公司,他于1974年加入,在意大利。百特,bonanni花了半个多他在国际业务的职业生涯,包括在比利时布鲁塞尔八年以上,在该公司的欧洲总部。

bonanni获得博士学位在化学,最优异成绩,荣誉提到,从佛罗伦萨大学,并在技术麻省理工学院的确在生理化学博士后工作。他是学院的国际管理,西北大学,J.L的校友凯洛格管理研究生院,并在制造管理程序,哈佛大学工商管理研究生院。

目前,博士。 bonanni是董事会成员和stevanato基,意大利公司开发和制造高品质的主要容器,设备和设备进行生物制药行业的内部审计委员会主席。他还担任incube实验室,圣何塞,加利福尼亚州,根据公司致力于创新医疗技术的发现和开发的顾问委员会成员。

迈克尔学家cleare headshot

迈克尔学家cleare

助理副教务长进行研究,宾夕法尼亚大学

从2000- 2007年,Mike是科技企业在纽约哥伦比亚大学的执行董事。这个位置包括在哥伦比亚和涉及许可的所有技术转让活动的责任,分拆/启动与IP公司,产业研究经费与国内和国际伙伴关系。 2007年8月,迈克加入宾夕法尼亚大学协理副教务长进行研究,负责所有技术转让,知识产权管理和工业联络活动。

Before joining Columbia University, Mike Cleare worked for 30 years at Johnson Matthey, a UK-based multinational world leader in advanced materials technology. His experiences range from the Senior R&D Executive through Business Development to a range of senior business management positions, and included service on the main Board of the Company for four years. While in R&D, Mike was involved in the discovery and development of a major new class of anti-cancer drugs; he is credited as one of the inventors of the platinum-based drug carboplatin. He served as President of several of the company's major divisions, including Pharmaceutical Materials, Chemicals and Metals, Catalytic Systems and Electronic Materials. He has managed complex global business, negotiated and closed multi-million dollar licensing and technology transfer deals, and entered into multiple research funding agreements with major universities. For nine years, Mike was a member of the board of directors of the Canadian biotechnology company, AnorMed, which he helped to spin off from Johnson Matthey in 1996. He has published more than 40 articles and papers and holds 10 patents.

博士。 cleare作为董事会的一员,亚利桑那州科技企业(azte),对亚利桑那州立大学的独家知识产权管理和技术转移机构。

迈克尔·达尔·贝洛 headshot

迈克尔·达尔·贝洛

在普利兹克一批民营医疗资本的投资合伙人

Michael is an Investment Partner at Pritzker Private Capital leading the firm’s Healthcare sector investing. Prior to joining Pritzker Private Capital, Michael was a Managing Director at Blackstone Capital Partners, with an aggregate $63 billion of assets under management in private equity. During his tenure at Blackstone, Michael helped lead sourcing efforts in healthcare and insurance, investing more than $7 billion of equity capital in 13 transactions. Michael also served on ten corporate boards, working with management teams to drive value through operational improvements, acquisitions and divestitures. Before joining Blackstone, Michael was an Associate at Hellman & Friedman where he was involved with the analysis and execution of private equity investments in the media and professional services sectors. Prior to that, Michael worked as a consultant at Bain & Company and also was a Research Associate at the China Center for Economic Research in Beijing, PR China as a Luce Scholar.

迈克尔赢得了由哈佛商学院的MBA学位,拥有牛津大学的本科学位,从沃顿商学院的硕士学位和艺术与科学学院在宾夕法尼亚大学学院。他是外交关系理事会的成员。

朱迪gasson headshot

朱迪gasson

高级顾问,澳彩网戴维·格芬医学院

Judith C. Gasson, a professor of biological chemistry and medicine, became director of UCLA’s Jonsson Comprehensive Cancer Center in 1995. A molecular biologist, Gasson is responsible for one of only 39 institutions nationwide designated as comprehensive cancer centers by the National Cancer Institute. In addition to her administrative duties, Gasson also is a gifted scientist. She was instrumental in purifying for the first time a hormone-like substance that increases the speed of bone marrow cell reproduction. That substance, called GM-CSF, is used to help prevent infections in cancer patients, and to allow patients to tolerate more chemotherapy and radiation than had previously been possible. In 2005, Gasson was named a co-director of the UCLA Institute of Stem Cell Biology and Medicine and she recently testified before a key Senate subcommittee on the promise of stem cell research in cancer. Gasson also serves as a board member for the American Association for Cancer Research. She earned a bachelor’s degree in microbiology from Colorado State University and a doctorate in physiology at the University of Colorado. Gasson did post doctoral work at the Salk Institute in La Jolla. In 1983, she left the Salk Institute to join UCLA's Jonsson Cancer Center, which comprises more than 240 researchers and clinicians engaged in research, prevention, detection, control, treatment and education. One of the nation's largest comprehensive cancer centers, the Jonsson center is dedicated to promoting research and translating the results into leading-edge clinical studies. In July 2005, the Jonsson Cancer Center was named the best cancer center in the western United States by U.S. 新闻 & World Report, a ranking it has held for six consecutive years.

大卫吉尔曼 headshot

大卫吉尔曼

Global Head-Portfolio Management, Business Development & 许可, Novartis Oncology

大卫花了近25年的工作,以协助客户的生命科学创新战略。这项工作包括一系列的投资,交易和合作伙伴策略。大卫花了大多数他的职业生涯在纽约和以色列弗兰克尔集团的执行董事,最近担任休伦的生命科学战略团队的董事总经理和铅。除了客户端的工作,大卫花时间教生命科学业务的学生和企业对医学生。 David拥有芝加哥大学和得克萨斯大学奥斯汀分校的MBA在东亚历史学学位。大卫,Jaime和他们的两个女儿住在山顶,新泽西州。

卡尔即古尔布兰德森 headshot

卡尔即古尔布兰德森

威斯康星校友研究基金会前董事总经理/ CEO(WARF)

卡尔即古尔布兰德森 is the Emeritus Managing Director of Wisconsin Alumni Research Foundation (WARF). WARF is the patent management organization for the University of Wisconsin Madison. He has a Ph.D. in physiology and a J.D. degree, both from UW –Madison. Gulbrandsen was with WARF from October, 1997 until July,2016. Prior to becoming its Managing Director in 2000, Gulbrandsen was WARF’s Director of Patents & 许可. Prior to his employment at WARF, Gulbrandsen was General Counsel of Lunar Corporation and Bone Care International. Both companies developed and commercialized technologies arising from research at UW-Madison. Gulbrandsen is Vice Chair and board member of the Morgridge Institute for Research. He also serves on the Board of WiCell Research Institute. Gulbrandsen is admitted to practice before the United States Patent and Trademark Office and served as a member of the Patent Public Advisory Council for the United States Patent and Trademark Office. Gulbrandsen and his wife, Mary, have three children and four grandchildren.

香农·汉森 headshot

香农·汉森

司副总裁兼副总法律顾问雅培制药

Ms. Hansen heads the legal group of Abbott Diabetes Care, located in Alameda, California, a global healthcare company focused on diagnostic and medical devices and other products for people living with diabetes. At Abbott, Ms. Hansen provides advice to management on all legal aspects of technology licensing, patent strategies, business development, R&D, procurement, sales, marketing, and other matters impacting the Diabetes Care division. Prior to this role, Ms. Hansen led the IP Group of Abbott Diabetes where she managed the patent group responsible for strategic patenting, licensing including academic licensing, IP litigation, and business counseling.

加盟雅培,MS之前。汉森曾担任美国专利与商标局,她表示在专利,商标,和纪律问题的上诉和地方法院美国专利商标局联营律师。她建议在专利政策美国专利商标局和其他行政办公室和国会的各种专利改革法案的工作。她还与总检察长的工作和公正的若干知识产权案件的部门,美国以前听过最高法院。

Prior to this role at the Patent and Trademark Office, Ms. Hansen practiced law for over 10 years with the Los Angeles office of Kirkland & Ellis, LLP where she focused on IP counseling including licensing and conducting due diligence for the IP aspects of corporate deals, and complex commercial litigation, including patent, trademark, copyright, and antitrust litigation. As a Partner of the firm, she represented clients in a variety of businesses including biotechnology, telecommunications, software, and chemical industries. As part of her outreach activities through the firm, Ms. Hansen served as a judge for moot court competitions for the UCLA School of Law. Ms. Hansen also worked on various corporate and intellectual property matters in the international group at Mori Hamada & Matsumoto Law Offices in Tokyo, Japan.

Before embarking in a career in law, Ms. Hansen was a product development engineer for E.I. du Pont de Nemours & Co. where she was responsible for new product development, implementing new technology developed in the research organization, and ensuring compliance with various environmental laws.

克里斯托夫·赫斯 headshot

克里斯托夫·赫斯

首席创新官,默克

Christoph Huels is responsible for the corporate innovation strategy and the technology foresight at Merck KGaA, Darmstadt, Germany. He is experienced in different businesses at Merck in Healthcare as well as Performance Materials (specialty chemicals). Including operational excellence in R&D, licensing, bio-partnering as well as the Corporate Venture Fund of Merck. Before joining Merck in 2008, he was CEO of Protagen AG, a German biotech company focussing on high value services in protein analysis especially under GMP, tool and software development for R&D in proteomics and the development of diagnostics based on a technology platform around protein biochips. He managed there several rounds of financing for the development of diagnostics as well as the build-up of a profitable service business in protein analysis. From 1999 to 2001 Christoph was responsible for project and portfolio management at Azupharma GmbH and CoKG, the German subsidiary of the Generics business of the Novartis group. He started his professional career in 1994 at Hoechst AG. After two years in the pharma division of Hoechst (today Sanofi) in Rheumatology/Immunology early phase drug development, he was working in increasing responsibility on projects in cell adhesion, protein evolution and RNA-splicing in the Central Research department. Christoph received his PhD in Biology from the Johannes-Gutenberg-University in Mainz at the Institute of Immunology.

绫jakobovits headshot

绫jakobovits

创始人,总裁,首席执行官和董事,adicet生物,INC。

Dr. Jakobovits is the Founder, President and CEO of Adicet Bio, Inc., a biopharmaceutical company, which together with its wholly-owned Israeli subsidiary, Adicet Bio Israel, is focused on the development of next-generation immunotherapies. Prior to starting Adicet, Dr. Jakobovits served as a Venture Partner with 要么biMed Advisors. From 2010-2013 she served as President & Founding CEO of Kite Pharma Inc., a leader in autologous T cell therapy. Prior to Kite Pharma, she served as Executive Vice President, Head of Research and Development at Agensys Inc., an affiliate of Astellas Pharma, Inc. Before Agensys’ acquisition in 2007, for a deal value of $537 million, she served as Senior Vice President, Technology and Corporate Development and Chief Scientific Officer, and led Agensys transition from a small gene discovery lab into a fully integrated biotech company with a proprietary portfolio of novel cancer targets and a clinical pipeline of cancer therapeutic antibodies. Before Agensys, Dr. Jakobovits served as Director, Discovery Research and Principal Scientist at Abgenix Inc., which was spun out of Cell Genesys based on XenoMouse® technology developed under her leadership. Abgenix was acquired by Amgen for $2.2 billion.

博士。 jakobovits获得了博士学位从科学的魏兹曼研究所,以色列,生命科学,是在Genentech和加州大学旧金山分校的博士后研究员。博士。 jakobovits超过50科学出版物的作者和发明者超过100项专利。

rajit马尔霍特拉 headshot

rajit马尔霍特拉

执行主席,生物制药符号

rajit马尔霍特拉是一个科技企业家,高管和投资者。他在投资,提供咨询和帮助建立快速增长,早期阶段的公司。他在医疗保健在广泛的行业,包括生物医药,人工智能,能源和房地产深厚的专业知识,以及丰富的经验。他是在生物制药符号执行主席,快速增长的公司。他也是旅游发动机的执行主席,一种新型的内燃机技术为基础的业务。他还建议其他公司,无论是在他的投资组合之外。

Rajit founded his first business while still in college, building it into the largest retail chain of Paint Technology stores in Oman & Dubai. He was a co-founder and board member of one of India’s largest biotech companies, Shantha Biotech, which was sold to Sanofi Aventis for over $850M in 2009. Amongst a few other ventures, he engineered a rapid performance turnaround at one of the largest pharmacy chains in Oman.

在2002年,rajit加入麦肯锡的洛杉矶办公室,并最终接任为南加州地区的管理合伙人,直到2016年离开,而在麦肯锡,他劝告首席执行官,董事会和高级管理人员在财富500家强企业,他的领袖医疗保健,公共部门和epng做法。他的医疗保健客户包括生物制药,医疗产品制造商,供应商和分销公司。他积累了在广泛的C-套房层面的问题,包括组织变革,发展战略,商业卓越,能力建设,并购和推动大规模变革的丰富经验。

rajit住在洛杉矶与他的两个孩子和金毛猎犬。他积极参与了一些市民和慈善项目。 rajit是澳彩网科技发展公司的董事会和cafam博物馆。他一直对院长在哈佛大学肯尼迪学院校友领导委员会,南加州领导委员会的成员之一,与萨班义诊的董事会成员。他杨荣文在90年代中期阿曼分会的创始成员,目前是一名成员,执行委员会YPO的贝莱尔章。

rajit收到MPA / ID哈佛大学肯尼迪政治学院和他在西北大学MBA学位凯洛格。他对商业的双本科学位和沃顿商学院的文科,并在宾夕法尼亚州,在那里他毕业以优异成绩大学学院。

约翰吨。 MAPES headshot

约翰吨。 MAPES

管理合伙人,极光资本伙伴

约翰MAPES是极光资本伙伴和投资委员会主席的管理合伙人。他花了他的整个23年职业生涯在金融服务领域。

极光资本合伙公司成立于1991年与所管理的资产超过$ 2.0十亿,极光是一家私人股权投资公司,在全国范围内跨多个基金投资于中间市场公司。极光资本伙伴目前投资了第六届基金。该公司收购控制等行业的公司中的利益:专业制造,分销和软件/启用高科技的服务。除了领先的公司的私募股权业务,约翰是公司执行委员会的成员。而他与经过多年的其他极光投资企业丰富经验的董事会,约翰目前是国家技术系统和餐厅Technologies,Inc.的董事会成员。

之后从1990年,当约翰打网球代表队的熊经济学/商业学士学位,澳彩网毕业,他花了两年时间与所罗门兄弟公司,INC。在纽约和洛杉矶,在他们的公司金融组织。他离开所罗门兄弟公司的加盟极光于1992年,随后出席并于1995年从哈佛商学院毕业后重新加入该公司。

约翰和他的妻子都在UCLA进入大二上学期有一子就读坎伯霍尔高中的女儿。他曾参与与特奥会和ST社会。马修的教区会,负责监督在圣教会和主教走读学校。马修教堂。他还代表加州哈佛商学院的活跃。

His wife Carrie earned a BA in History in 1990 and a Master’s in Education and Multiple Subject Instruction Credential in 1991. Carrie belongs to Women & Philanthropy and is a lifetime member of the Alumni Association. The Mapes endowed five student-athlete scholarships at UCLA—two in men’s tennis, football, men’s basketball, and women’s beach volleyball. Additionally, the Mapes funded a gift to support the construction of new beach volleyball courts at UCLA which will be known on campus as Mapes Beach. John currently serves on the Athletics Centennial Campaign Committee, Chairs the UCLA Athletic Hall of Fame Committee and serves on the UCLA Technology Development Corporation Board.

人奥斯本 Photo

人奥斯本

临时院长,澳彩网安德森管理学院

Alfred E. Osborne, Jr., is interim dean of the UCLA Anderson School of Management, overseeing its key objectives to conduct essential research, educate students and serve the community. Previously, he served as the school's senior associate dean, overseeing such key initiatives as resource development, alumni relations, corporate initiatives and executive education. A professor of global economics, management and entrepreneurship, Osborne is also the founder and faculty director of Anderson's Harold and Pauline Price Center for Entrepreneurship & Innovation. His academic expertise and interests include social entrepreneurship and the development of a leadership approach that applies business models and methodologies to the nonprofit world. He holds four degrees from Stanford University, including a Ph.D. in business economics and an MBA in finance.

罗伯特pacifici博士 headshot

罗伯特pacifici博士

首席科学官,CHDI基金会

罗伯特pacifici是CHDI基金会,私人,不以营利为目的的研究机构,科学家组成的国际网络工程,以加快亨廷顿氏病治疗发展的首席科学官。此前,他是现场导演兼首席科学官礼来公司的Research Triangle Park的实验室。在那里,他负责公司的全球筛选和定量生物学的努力。之前加入礼来公司,pacifici在xencor,施加合理的设计原则,以蛋白质药物的发展pri¬vately举行的生物技术公司发现技术副总裁。在安进了近十年,pacifici举行的职责包括提高领导他们的自动化,高通量筛选和信息技术组的位置。

pacifici专业学士学位生物化学马萨诸塞大学阿姆赫斯特分校,并从南加州大学生物化学博士学位。 CHDI以外,目前pacifici参与几个外部板和咨询com¬mittees包括:

  • 国际中心监管科学的监事USC板
  • 成员,脊髓性肌萎缩症基金会科学顾问委员会
  • 构件,明石科学顾问委员会

pacifici曾担任上:

  • 理事会成员的神经系统疾病和中风的健康/国家研究所的国家研究院(NIH / NINDS)从2011年至2014
  • 椅子,工作组为NINDS的抗惊厥筛选计划
  • 椅子,NIH / NINDS脊髓性肌萎缩项目科学指导委员会
  • 顾问,对于强直性肌营养不良万寿菊基础
  • 顾问,国际合作神经肌肉群(cinrg)的杜氏肌营养不良症研究中心(dmdrc)和中心遗传医学研究在国家儿童医学中心的临床研究机构(CNMC)
  • 部件,爱迪生制药科学顾问委员会
  • 成员,治疗ALS指导委员会
  • 构件,面肩肱型肌营养不良症的咨询委员会的发病机制
  • 专家为国家中心在美国国立卫生研究院推进平移科学(ncats),在美国国立卫生研究院中心平移疗法(nctt)的面板。这种分工是家庭对两个方案寻求通过后期临床前开发阶段来推进有前途的治疗药物:罕见疗法和被忽视的疾病(TRND),和桥接介入发展差距(bridgs)

罗伯特还于非科学能力总裁与美国亚洲协会交响乐。罗伯特,他的妻子eunjoo,和他的两个孩子萨日娜和诺亚,住在洛斯维第斯庄园加州。罗伯特是一个狂热的业余公路自行车选手和经典的宝马爱好者。

马特和pENDO headshot

马特和pENDO

橡树

先生。从和pENDO奥尼尔桑德勒合作伙伴,在那里他是董事总经理主要集中在金融服务行业的投资银行业务精品在2015年加入了橡树。在此之前,先生。和pENDO是美国的问题资产救助计划(TARP)的首席投资官库房,在那里他与杰出服务奖授予的部门。在那里,他建立和管理一个团队的20名专业人员跨多个行业,包括美国国际集团,通用汽车公司和银行,以及资本结构的各个层次监督国库的$ 200十亿不良资产救助计划的投资活动。先生。和pENDO在美林,他在那里度过了18年,成为科技产业集团的总经理之前,开始在其投资银行部门开始了他的职业生涯。随后,先生。和pENDO是巴克莱资本董事总经理,第一服务美国作为联席主管投资银行和全球工业集团的再联席主管。他获得了学士学位,在经济学普林斯顿大学,成绩优异,是SUPERVALU Inc.的董事会成员。

芭芭拉ķ。 sosnowski headshot

芭芭拉ķ。 sosnowski

Vice President and Global Head – External R&D Innovation – Pharmatherapeutics and WRD External Partnerships, Pfizer, Inc.

Barbara Sosnowski is Vice President and Global Head, External R&D Innovation Pharmatherapeutics and WRD External Partnerships. As part of the Pharmatherapeutics team, Barbara is the cluster lead for Cardiovascular Metabolic and Inflammation and Immunology Research Units for externally focused efforts. Dr. Sosnowski has more than 30 years in the health care industry. Prior to joining Pfizer 6 years ago, Barbara was Vice President, Biologics Development of Cardium Therapeutics and was appointed Chief Operating Officer of Tissue Repair Company following Cardium’s acquisition of Tissue Repair Company in August 2006. Prior to the acquisition, Dr. Sosnowski served as President and CEO of Tissue Repair Company. From June 2001 to December 2004 she served as Vice President Research and Development of Selective Genetics Inc. a tissue repair company that developed wound repair, orthopedic and cardiovascular products. At Selective Genetics, she co-invented and helped develop the targeted gene therapy program, both viral and non-viral. Prior to Selective Genetics she was employed by Prizm Pharmaceuticals from October 1992. Prior to joining Prizm, Dr. Sosnowski was at Ligand Pharmaceuticals, where her efforts were focused on identification of small molecule inhibitors of osteoporosis. Dr. Sosnowski received her BA in Biological Sciences from the University of California, Berkeley and PhD in Biological Sciences from Johns Hopkins University. She is also a registered patent agent.

斯蒂芬yslas headshot

斯蒂芬yslas

公司副总裁兼总法律顾问,Northrop Grumman公司

先生。 yslas担任Northrop Grumman公司的公司副总裁兼总法律顾问。此前,他曾担任诺·格公司副总裁,书记,副法律总顾问和首席法律顾问公司的飞机和电子业务,也导致监管事项的法律团队,包括那些涉及利顿,纽波特纽斯和TRW的收购。他的职责包括国际化,并购,出口管制,劳动就业,员工福利,环境,反垄断,知识产权,其他联邦和州监管事宜,以及华盛顿办事处的法律支持。

于1975年加入该公司之前,yslas曾为大西洋富田公司与国家劳工关系委员会。他担任了10年的洛杉矶市警察委员会的一名警察局长。

先生。 yslas已与各种非营利组织和社区组织,包括西班牙国家和墨西哥裔美国律师协会。他是拉丁裔民选和任命官员的全国协会的创始成员之一。他还兼任克莱蒙特·麦肯纳学院的受托人。他担任宪法权利基金会的董事会成员和警察纪念基金会。